Woudenberg Michael

Woudenberg Michael is listed in filings as Chief Operating Officer at InMed Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Dec 19, 2025, including 3 public disclosures. Recent filings connect the profile to InMed Pharmaceuticals Inc. (INM). The current snapshot covers public activity from Dec 23, 2024 to Dec 19, 2025. Reported amounts are shown as $23.2K to $15.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.